Access to Health Care

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

Access to Health Care Resources:

Debunking Myths about the Enhanced ACA Tax Credits

October 11, 2024

This factsheet seeks to debunk some of the misinformation that has been made about the enhanced ACA tax credits.

ACS CAN Factsheet: Enhanced ACA tax credits have helped historically marginalized communities

October 9, 2024

This factsheet shows how the enhanced ACA tax credits have benefitted historically marginalized communities.

Cancer Patients & Survivors Overwhelmingly Support Extending ACA Enhanced Tax Credits

October 8, 2024

In our latest survey, cancer patients and survivors overwhelmingly support extending financial assistance for people who purchase health coverage through the Affordable Care Act marketplace by a margin of nearly 12 to 1 (72% support, 6% oppose). The survey also finds 43% would not be able to afford their plan without the enhanced tax credits, 30% would skip or delay medical care to reduce expenses, and 24% would accumulate medical debt to afford their care.

Prescription Drug Affordability Boards and the Impact on Cancer Care

October 4, 2024

ACS CAN has long fought for public policies that support the availability and affordability of medically necessary prescription drugs.

Congress Must Extend the Enhanced ACA Tax Credits

May 10, 2024

Having affordable and comprehensive health insurance coverage is a key determinant for surviving cancer.

Survivor Views: Majority of Cancer Patients & Survivors Have or Expect to Have Medical Debt

May 9, 2024

Our latest survey finds that about half of cancer patients and survivors (49%) have incurred medical debt to pay for their cancer care and another 13% expect to incur medical debt as they begin or continue their treatment. Nearly all of those (98%) had health care coverage at the time they accumulated medical debt. This survey also explores the broad health and financial implications of medical debt, how medical debt deepens inequites, and the alarming rate of cancer related medical debt among younger respondents with early diagnoses.

ACS and ACS CAN letter regarding CMS data

March 22, 2024

Addressing Cancer Disparities in LGBTQ+ Communities

March 20, 2024

A critical factor for eliminating disparities and ensuring health equity is the guarantee that all people have access to quality, affordable health care.

Factors Influencing Cancer Disparities

January 11, 2024

The American Cancer Society Cancer Action Network (ACS CAN) believes everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of income, race, gender identity, sexual orientation, disability status, or where they live. From preventive screening and early detection, through diagnosis and treatment, and into survivorship, there are several factors that influence cancer disparities among different populations across the cancer continuum.

Prescription Drug Affordability Resources:

ACS CAN Factsheet: Enhanced ACA Tax Credits' Impact on Rural Communities

December 13, 2024

This factsheet provides background information on how the enhanced ACA tax credits benefit those in rural communities.

ACS CAN Enhanced ACA Tax Credit Factsheet

October 9, 2024

This factsheet provides basic information about the enhanced ACA tax credits.

Prescription Drug Affordability Boards and the Impact on Cancer Care

October 4, 2024

ACS CAN has long fought for public policies that support the availability and affordability of medically necessary prescription drugs.

Patient Assistance Programs

November 1, 2023

Patient Assistance Programs

Comments to CMS re: Medicare Drug Price Negotiation Program

September 12, 2023

Survivor Views: Copay Assistance and Patient Navigation

July 18, 2022

Prescription drug costs are a significant burden on cancer patients and survivors, sometimes even leading patients to miss or delay taking prescribed medications. The latest Survivor Views survey explores the role copay assistance programs can play in reducing this burden, and also addresses patient navigation and digital therapeutics.

Survivor Views: Affordability, Prescription Drugs, & Pain

December 15, 2021

A majority of cancer patients and survivors struggle to afford cancer care and over 80% have had to make financial sacrifices to cover their health care expenses. This survey also reveals ways that affordability concerns can negatively impact care and treatment, and explores issues related to prescription drug coverage and pain management options.

Some Patients Lack Access to Lower-cost Drug Alternatives

November 3, 2020

Many cancer patients take multiple drugs as part of their treatment – often for many months or years. While drugs are not the only costly part of cancer treatment, finding ways to reduce these costs for patients and payers will significantly reduce the overall cost burden of cancer.

Survivor Views: Surprise Billing and Prescription Cost and Coverage Survey Findings Summary

December 4, 2019

This Survivor Views survey examined access to and affordability of cancer care. Survivors report insurance-related barriers to obtaining prescriptions, and lower-income respondents in particular have difficulty affording them. 24% of respondents have received a surprise medical bill, 60% of which were more than $500.

Private Health Insurance Resources:

ACS CAN Comments re: 2023 Notice of Benefit and Payment Parameters

January 27, 2022

ACS CAN submitted comments regarding marketplace insurance plans and requirements for plan year 2023.

ACS CAN comments re: Agent and Broker Disclosures

October 14, 2021

High Deductible Health Plans, Health Savings Accounts and Cancer Patients

November 10, 2020

High deductible health plans (HDHPs) and health savings accounts (HSAs) are becoming more common in employer-sponsored insurance and the individual and small group markets. These types of plans have risks and features must be implemented carefully so they do not harm cancer patients, survivors or those at risk for cancer.

ACS CAN Comments re: 2020 Notice of Benefit & Payment Parameters

February 19, 2019

ACS CAN submitted comments regarding the 2020 Proposed Notice of Benefit & Payment Parameters for the individual insurance market.

ACS CAN Comments on 2019 CMS Program Integrity Rule

January 8, 2019

ACS CAN submitted comments on the proposed 2019 CMS Program Integrity Rule.

ACS CAN Comments re: Health Reimbursement Arrangements

December 28, 2018

ACS CAN submitted comments regarding a proposed rule to change Health Reimbursement Arrangements (HRAs) and other account-based group health plans.

ACS CAN Examination of Cancer Drug Coverage and Transparency in the Health Insurance Marketplaces

November 18, 2015

In 2015, the American Cancer Society Cancer Action Network (ACS CAN) analyzed coverage of cancer drugs in the health insurance marketplaces created by the Affordable Care Act (ACA) and found that transparency of coverage and cost-sharing requirements were insufficient to allow cancer patients to choose the best plan for their needs.

Cancer Drug Coverage in Health Insurance Marketplace Plans (2014)

March 1, 2014

This analysis examines two issues of particular interest to the American Cancer Society Cancer Action Network (ACS CAN) and its members: the extent of coverage and cost-sharing for cancer drugs, and whether information on the coverage of cancer drugs can be readily obtained, compared, and understood by patients.

Medicare Resources:

ACS CAN comments on Medicare Hospital Outpatient proposed rule

September 9, 2024

ACS CAN offered comments on the following proposals:

ACS CAN comments on Medicare Physician Fee Schedule proposed rule

September 9, 2024

ACS CAN offered comments on the following policies:

Step Therapy in Medicare Part D Oncology Drugs

May 21, 2024

Executive Summary

Utilization Management in Breast Cancer and Hepatocellular Carcinoma

May 21, 2024

Executive Summary

ACS CAN comments on Medicare Prescription Payment Plan model notices

April 29, 2024

On Monday, April 29th, ACS CAN submitted comments in response to CMS' Medicare Prescription Payment Plan model notices.

ACS CAN Comments on Medicare Prescription Payment Plan second guidance

April 9, 2024

Cancer in Medicare: An American Cancer Society Cancer Action Network Chartbook

January 23, 2024

This ACS CAN chartbook provides cancer-specific data related to Medicare, including basic information about the program, a discussion of its components, characteristics of enrollees, coverage of services – specifically those related to prevention and screening – program expenditures and enrollees

Examining the Impact of Site Neutral Payment on Costs for Cancer Care

October 23, 2023

Key Findings

ACS & ACS CAN and Partners Joint Comments on Patient Navigation Provisions of CY2024 Medicare Physician Fee Schedule Proposed Rule

September 8, 2023

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) along with partners appreciate the opportunity to comment on the Patient Navigation provisions of CY2024 Medicare Physician Fee Schedule.

Costs and Barriers to Care Resources:

ACS CAN Comments re: Removing Medical Debt from Credit Reports

August 9, 2024

ACS CAN submitted comments to the Consumer Financial Protection Bureau strongly supporting the proposal to prohibit medical debt from appearing on credit reports.

Comments to CMS re: Medical Debt Questions in Medicare Survey

June 24, 2024

Medical Debt and Cancer

May 9, 2024

Medical debt impacts many people with cancer, their caregivers and their families. This factsheet details this impact and explores policy solutions to prevent medical debt and minimize its impact on health, quality of life and financial health.

Survivor Views: Majority of Cancer Patients & Survivors Have or Expect to Have Medical Debt

May 9, 2024

Survivor Views: Preventive Care Coverage, Medical Debt, & Food Insecurity

February 14, 2024

Our latest survey finds that protecting no-cost screenings and preventive care and reducing the burden of medical debt are the most impotant priorities for cancer patients and survivors. This survey also explores the impacts of cancer on food and nutrition insecurity, with impacts felt across income groups and coverage levels.

Impacts of Medical Debt: Findings from a National Survey

October 30, 2023

ACS CAN partnered with the Leukemia and Lymphoma Society and RIP Medical Debt to conduct a national survey on the impacts of medical debt and high health care costs. Read the full results.

Trapped: America's Crippling Medical Debt Crisis

October 30, 2023

ACS CAN teamed up with the Leukemia and Lymphoma Society and RIP Medical Debt to conduct a national survey on the impacts of medical debt and high health care costs. Read a summary of the results.

Short-Term Limited Duration Health Plans Leave Cancer Patients Vulnerable to Extremely High Out-of-Pocket Costs

June 30, 2022

Short-term limited duration (STLD) insurance plans do not provide the kind of comprehensive insurance coverage cancer patients need. These plans were designed only as temporary coverage and are not subject to the same Affordable Care Act (ACA) requirements as other health insurance products on the market. As a result, an enrollee who was attracted to the plan’s lower premiums may find – if they are diagnosed with a serious illness like cancer – that the plan does not cover all of their necessary cancer treatments. In these cases, the consumer can be left with catastrophic costs.

Out-of-Pocket Spending Limits Are Crucial for Cancer Patients & Survivors

January 4, 2022

Many patients with complex diseases like cancer find it difficult to afford their treatments – even when they have health insurance. Current law establishes a limit on what most private insurance plans can require enrollees to pay in out-of-pocket costs. These limits protect patients from extremely high costs and are essential to any health care system that works for cancer patients and survivors.

Medicaid Resources:

Medicaid Expansion & The End of Continuous Coverage in Mississippi

May 3, 2023

What does unwinding continuous coverage have to do with Medicaid expansion?

During the pandemic, Congress put in place continuous coverage protections to ensure that Medicaid enrollees were able to keep their health coverage without needing to re-enroll.

Medicaid Expansion & The End of Continuous Coverage in Kansas

May 3, 2023

What does unwinding continuous coverage have to do with Medicaid expansion?

During the pandemic, Congress put in place continuous coverage protections to ensure that Medicaid enrollees were able to keep their health coverage without needing to re-enroll.

Medicaid Expansion & The End of Continuous Coverage in Florida

May 3, 2023

What does unwinding continuous coverage have to do with Medicaid expansion?

During the pandemic, Congress put in place continuous coverage protections to ensure that Medicaid enrollees were able to keep their health coverage without needing to re-enroll.

Medicaid Expansion & The End of Continuous Coverage in Georgia

April 28, 2023

What does unwinding continuous coverage have to do with Medicaid expansion?

During the pandemic, Congress put in place continuous coverage protections to ensure that Medicaid enrollees were able to keep their health coverage without needing to re-enroll.

Medicaid Expansion & The End of Continuous Coverage in Alabama

April 26, 2023

What does unwinding continuous coverage have to do with Medicaid expansion?

During the pandemic, Congress put in place continuous coverage protections to ensure that Medicaid enrollees were able to keep their health coverage without needing to re-enroll.

Share